Overcoming Systemic MCO Barriers to Patient-Centric Rheumatoid Arthritis Care: Embracing Self-Reported Outcomes to Maximize Value and Patient Satisfaction
Overcoming Systemic MCO Barriers to Patient-Centric Rheumatoid Arthritis Care: Embracing Self-Reported Outcomes to Maximize Value and Patient Satisfaction
On-Demand Webcast
Faculty
William J. Cardarelli, PharmD
Director of Pharmacy Revenue and Supply
Atrius Health
Harvard Vanguard Medical Associates
Watertown, Massachusetts
Alan L. Epstein, MD
Clinical Associate Professor of Medicine
University of Pennsylvania School of Medicine
Assistant Physician to the Hospital in Rheumatology
Pennsylvania Hospital
Private Practice
Philadelphia, Pennsylvania
Intended Learners
This activity is designed for managed markets physicians and pharmacists.
Learning Objectives
After completing this activity, participants should be able to:
- Compare and contrast available health assessment questionnaires (HAQs) and outline their utility to determine patient health status and response to therapy
- Integrate patient reported outcome (PRO) efficacy data to formulary review
- Identify and overcome systemic barriers to PRO utilization in the treatment of patients with rheumatoid arthritis (RA)
Activity Overview
This on-demand webcast is available with synchronized slides and audio.
To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question online post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.
Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.
Release Date: April 5, 2013
Expiration Date: April 5, 2014
Estimated time to complete: 1 hour
There is no fee associated with this activity.
This educational activity is a knowledge-based activity.
For questions regarding this educational activity, please call 609-371-1137.
Access Instructions
To access the live webinar, click the “Access Webinar” link on the top right side of the page. Please note that once you click on this link, a new window will open, and you will need to enter the requested contact information to proceed to the webinar. You will also receive an email at this time from NACCME Presenter with detailed instructions on how to access the webinar at the appropriate time. Prior to accessing the webinar, you will be prompted to download and install GoToWebinar. Please allow 15 minutes for this process.
If you are listening in a group, each participant must register as a NACCME user to be able to take their individual post-test and evaluation form, and print their documentation of credit. To register, go to www.naccme.com.
Hardware/Software Requirements
All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.
Accreditation
In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CME
NACCME designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CPE
This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education (UAN 0276-0000-13-022-H01-P).
Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact the Assistant Director, Accreditation Services, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535. The Assistant Director, Accreditation Services will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Executive Director, Accreditation Services, NACCME, may be made for a second level of review.
Independent Clinical Reviewer: Elinor A. Mody, MD, Director, Women’s Orthopedic and Joint Disease Program, Instructor, Harvard Medical School, Boston, Massachusetts
Planning Committee
The planning committee comprises William J. Cardarelli, PharmD, Alan L. Epstein, MD, Elinor A. Mody, MD; and Diane Borges, PhD, Stephen Chavez, Kristin Ciszeski, Mike Kearney, Randy Robbin, and John Savage, NACCME.
Financial Disclosure and Conflicts of Interest
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Dr. Epstein: Promotional speakers bureau—Abbott Immunology, Bristol-Myers Squibb, Crescendo Bioscience, Inc, Genentech, Inc, Janssen Pharmaceuticals, Inc
Dr. Cardarelli and Dr. Mody have disclosed no relevant financial relationships with any commercial interests
Dr. Borges, Mr. Chavez, Ms. Ciszeski, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.
Mr. Kearney: Stock Shareholder—Savient Pharmaceuticals, Inc.
NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.
The faculty have disclosed that no off-label/unapproved uses of drugs and/or devices will be discussed.
Privacy Policy
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2013 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
Grant Support
Supported by an educational grant from AbbVie, Inc.
